| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP0759757B1 Oral liquid alendronate formulations |
| 08/21/2002 | CN1365281A Metalloprotease inhibitors |
| 08/21/2002 | CN1364630A Rheumatic pain killing medicine powder |
| 08/21/2002 | CN1364627A Medicine for curing cervical spondylopathy and vertebrae lumbales diseases |
| 08/21/2002 | CN1364625A Medicine for curing lupus erythematosus |
| 08/21/2002 | CN1364621A Medicinal wine for curing rheumatism, rheumatoid and various diseases caused by wind and cold |
| 08/21/2002 | CN1364618A Rheumatism treating medicine powder |
| 08/21/2002 | CN1364609A External use medicine bag for stagnation-syndrome |
| 08/21/2002 | CN1364608A Powder for curing gout |
| 08/21/2002 | CN1364565A Nano wind-evil expelling medicine and its preparing method |
| 08/21/2002 | CN1364522A Nano Liaoyuanqili medicine and its preparing method |
| 08/21/2002 | CN1364520A Nano fengtong medicine and its preparing method |
| 08/21/2002 | CN1364511A Medicine for preventing and curing osteoporosis |
| 08/21/2002 | CN1364495A Nano traumatologic seven ingredient medicine and its preparing method |
| 08/21/2002 | CN1364493A Nano musk joint pain stopping medicine and its preparing method |
| 08/21/2002 | CN1364476A Nano five-tiger medicine and its preparing method |
| 08/21/2002 | CN1364464A Aminoglucose hydrochloride medicinal composition |
| 08/21/2002 | CN1089336C Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437094 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 08/20/2002 | US6436987 Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436913 Use of estramustine phosphate in the treatment of bone metastasis |
| 08/20/2002 | US6436911 IL-12 production inhibitor |
| 08/20/2002 | US6436902 Therapeutic preparations for inhalation |
| 08/20/2002 | US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/15/2002 | WO2002063033A1 Screening method |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062990A1 Antibody and utilization thereof |
| 08/15/2002 | WO2002062968A2 Micro-tubular materials and cell constructs |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | WO2002062794A2 Compounds |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 08/15/2002 | WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 08/15/2002 | WO2002062767A1 Novel quinazoline derivatives |
| 08/15/2002 | WO2002062756A1 Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as mmp inhibitors |
| 08/15/2002 | WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments |
| 08/15/2002 | WO2002062398A2 Radioactively labelled conjugates of phosphonates |
| 08/15/2002 | WO2002062357A1 Methods and devices for tissue repair |
| 08/15/2002 | WO2002062352A2 Devices and methods for management of bone density |
| 08/15/2002 | WO2002062351A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 08/15/2002 | WO2002062337A1 Thiazolidinediones |
| 08/15/2002 | WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | WO2002062293A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002032861A3 Orally active salts with tyrosine kinase activity |
| 08/15/2002 | WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002014870A3 Use of antibodies against specific mhc-peptide complexes |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | US20020111505 Purified 15-epi-lipoxin compound has a longer tissue half-life; anticancer agents |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111378 Inhibitors of IMPDH enzyme |
| 08/15/2002 | US20020111374 Estrogen receptor modulators |
| 08/15/2002 | US20020111373 Thiadiazolidin-2,4-dione compound |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111351 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110558 For therapy |
| 08/15/2002 | CA2438208A1 Devices and methods for management of bone density |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2437212A1 Methods and devices for tissue repair |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2434302A1 Therapeutic and diagnostic compounds, compositions, and methods |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230923A1 Tocotrienols as inhibitors for neovascularisation, cell multiplication, lumen formation and fgf |
| 08/14/2002 | EP1230920A1 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |